Long-term outcomes of Japan-specific dosage of rivaroxaban in high-risk patients with non-valvular atrial fibrillation: analysis from the XAPASS
29 August 2020 (00:00 - 00:00)
Organised by:
About the speaker
Toho University, Tokyo (Japan)
172 More presentations in this session
Doctor J. Sousa (Funchal, PT)
Doctor A. Lyon (Maastricht, NL)
Mr M. Nazarzadeh (Oxford, GB)
Access the full session
The Event
ESC Congress 2020
29 August - 1 September 2020
You may be interested in
Congress Session
Congress Presentation
